It was found that Pontin levels can be used as a biomarker to discriminate esophageal squamous-cell carcinoma (ESCC) from normal tissue (Lauscher et al., 2007, 2012; Tung et al., 2013). The gene discussed is RUVBL1; the disease is esophageal squamous cell carcinoma.